MedPath

An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)

Completed
Conditions
Psoriasis
Pregnancy
Registration Number
NCT00097240
Lead Sponsor
Genentech, Inc.
Brief Summary

The Raptiva Pregnancy Registry was a prospective observational study established to obtain data on pregnancy outcomes of women who were exposed to Raptiva.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
18
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

FOLLOW Raptiva Pregnancy Registry

🇺🇸

Morrisville, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath